← Back to catalogue

OneTouch Ultra2

FDA UDI

Class II (US FDA UDI)

by Lifescan Europe

Identity

Trade Name
OneTouch Ultra2 FDA UDI
Generic Name
Glucose IVD, kit, electrometry FDA UDI
Device Name
OneTouch Ultra2 Blood Glucose Monitoring System with Delica Lancing Device, not for resale or reimbursement. Uses OneTouch Ultra Blue Test strip FDA UDI
Model / Reference
021-100 FDA UDI
Description
OneTouch Ultra2 Blood Glucose Monitoring System with Delica Lancing Device, not for resale or reimbursement. Uses OneTouch Ultra Blue Test strip FDA UDI

Identifiers

Catalog Number
021-100 FDA UDI
Primary DI / UDI-DI
00353885008853 FDA UDI
510(k) Number
K053529 FDA UDI
FDA Product Code
CGA FDA UDI
NBW FDA UDI
GMDN Term
Glucose IVD, kit, electrometry FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
862.1345 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

Yes

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

Yes

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

Yes

FDA UDI

Dimensions & Sizes

Size
Needle Gauge — 30 Gauge FDA UDI

Category: Glucose monitoring system IVD, home-useGlucose IVD, kit, electrometryBlood lancing device tipManual blood lancing device, reusable

OneTouch Ultra2 by Lifescan Europe — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Manual blood lancing device, reusable.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Lifescan Europe

Sources (1)

  • FDA UDI 245f3a44-cc25-49bf-90ac-278bde9d77e8 38 fields · synced Jun 8, 2026